Hepatic infiltration and activation of MDSCs can be regulated by inflammatory chemokines (e.g., CXCL1 and CCL2) and cytokines (e.g., IL-6), tumor-associated fibroblasts, epigenetic factors, and gut microbiota during liver pathogenesis. The gene discussed is CCL2; the disease is neoplasm.